Exelixis (EXEL) EBT Growth (3y) (2013 - 2026)
Exelixis (EXEL) EBT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 9.34% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 40.43% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 12.01% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 86.16% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn | 76.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 76.99% |
| Jan 2, 2026 | 115.73% |
| Oct 3, 2025 | 39.97% |
| Jul 4, 2025 | 37.57% |
| Apr 4, 2025 | 34.13% |
| Jan 3, 2025 | 16.12% |
| Sep 27, 2024 | 42.70% |
| Jun 28, 2024 | 32.85% |
| Mar 29, 2024 | 197.95% |
| Dec 29, 2023 | 36.89% |
| Sep 29, 2023 | 29.13% |
| Jun 30, 2023 | 7.55% |
| Mar 31, 2023 | -7.01% |
| Dec 30, 2022 | -58.84% |
| Sep 30, 2022 | -9.13% |
| Jul 1, 2022 | -3.91% |
| Apr 1, 2022 | -2.04% |
| Dec 31, 2021 | 0.47% |
| Oct 1, 2021 | -25.53% |
| Jul 2, 2021 | 12.21% |